Literature DB >> 30472306

A comprehensive review on histone-mediated transfection for gene therapy.

Haobo Han1, Jiebing Yang1, Wenqi Chen1, Qing Li1, Yan Yang2, Quanshun Li3.   

Abstract

Histone has been considered to be an effective carrier in non-viral gene delivery due to its unique properties such as efficient DNA binding ability, direct translocation to cytoplasm and favorable nuclear localization ability. Meanwhile, the rapid development of genetic engineering techniques could facilitate the construction of multifunctional fusion proteins based on histone molecules to further improve the transfection efficiency. Remarkably, histone has been demonstrated to achieve gene transfection in a synergistic manner with cationic polymers, affording to a significant improvement of transfection efficiency. In the review, we highlighted the recent developments and future trends in gene delivery mediated by histones or histone-based fusion proteins/peptides. This review also discussed the mechanism of histone-mediated gene transfection and provided an outlook for future therapeutic opportunities in the viewpoint of transfection efficacy and biosafety.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fusion protein; Gene therapy; Histone; Synergistic effects; Transfection

Mesh:

Substances:

Year:  2018        PMID: 30472306     DOI: 10.1016/j.biotechadv.2018.11.009

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  4 in total

1.  Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids.

Authors:  Tobias Killian; Annette Buntz; Teresa Herlet; Heike Seul; Olaf Mundigl; Gernot Längst; Ulrich Brinkmann
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

Review 2.  Novel targeted therapies for Parkinson's disease.

Authors:  Theodora Ntetsika; Paraskevi-Evita Papathoma; Ioanna Markaki
Journal:  Mol Med       Date:  2021-02-25       Impact factor: 6.354

Review 3.  Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside.

Authors:  Teng Huang; Jia Gao; Long Cai; Hao Xie; Yuhan Wang; Yi Wang; Qing Zhou
Journal:  Pharmaceutics       Date:  2022-04-07       Impact factor: 6.525

4.  Functional Tumor Targeting Nano-Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single-Cell Level.

Authors:  Xiao-He Ren; Xiao-Yan He; Chang Xu; Di Han; Si-Xue Cheng
Journal:  Adv Sci (Weinh)       Date:  2022-05-20       Impact factor: 17.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.